Dublin, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The "Motion Sickness Treatment Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type" report has been added to ResearchAndMarkets.com's offering.
This report describes the global market size of Motion Sickness Treatment from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026.
For the geography segment, regional supply, demand, major players, price is presented from 2016 to 2026.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For the competitor segment, the report includes global key players of Motion Sickness Treatment as well as some small players.
The information for each competitor includes:
- Company Profile
- Main Business Information
- SWOT Analysis
- Sales Volume, Revenue, Price and Gross Margin
- Market Share
Applications Segment:
- Retail Pharmacies
- Online Pharmacies
- Others
Types Segment:
- Anticholinergic
- Antihistamines
- Others
Companies Covered:
- GlaxoSmithKline
- Perrigo Company
- Prestige Brands
- WellSpring Pharmaceutical Corporation
- Caleb Pharmaceuticals
- Myungmoon Pharm
- Baxter International
- Reliefband Technologies
Key Topics Covered:
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Motion Sickness Treatment Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Trading Analysis
8.1 Export of Motion Sickness Treatment by Region
8.2 Import of Motion Sickness Treatment by Region
8.3 Balance of Trade
Chapter 9 Historical and Forecast Motion Sickness Treatment Market in North America (2016-2026)
9.1 Motion Sickness Treatment Market Size
9.2 Motion Sickness Treatment Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis
9.5.1 United States
9.5.2 Canada
9.5.3 Mexico
Chapter 10 Historical and Forecast Motion Sickness Treatment Market in South America (2016-2026)
10.1 Motion Sickness Treatment Market Size
10.2 Motion Sickness Treatment Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Chile
10.5.4 Peru
Chapter 11 Historical and Forecast Motion Sickness Treatment Market in Asia & Pacific (2016-2026)
11.1 Motion Sickness Treatment Market Size
11.2 Motion Sickness Treatment Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis
11.5.1 China
11.5.2 India
11.5.3 Japan
11.5.4 South Korea
11.5.5 Southest Asia
11.5.6 Australia
Chapter 12 Historical and Forecast Motion Sickness Treatment Market in Europe (2016-2026)
12.1 Motion Sickness Treatment Market Size
12.2 Motion Sickness Treatment Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis
12.5.1 Germany
12.5.2 France
12.5.3 United Kingdom
12.5.4 Italy
12.5.5 Spain
12.5.6 Belgium
12.5.7 Netherlands
12.5.8 Austria
12.5.9 Poland
12.5.10 Russia
Chapter 13 Historical and Forecast Motion Sickness Treatment Market in MEA (2016-2026)
13.1 Motion Sickness Treatment Market Size
13.2 Motion Sickness Treatment Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis
13.5.1 Egypt
13.5.2 Israel
13.5.3 South Africa
13.5.4 Gulf Cooperation Council Countries
13.5.5 Turkey
Chapter 14 Summary For Global Motion Sickness Treatment Market (2016-2021)
14.1 Motion Sickness Treatment Market Size
14.2 Motion Sickness Treatment Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price
Chapter 15 Global Motion Sickness Treatment Market Forecast (2021-2026)
15.1 Motion Sickness Treatment Market Size Forecast
15.2 Motion Sickness Treatment Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast
Chapter 16 Analysis of Global Key Vendors
16.1 GlaxoSmithKline
16.1.1 Company Profile
16.1.2 Main Business and Motion Sickness Treatment Information
16.1.3 SWOT Analysis of GlaxoSmithKline
16.1.4 GlaxoSmithKline Motion Sickness Treatment Sales, Revenue, Price and Gross Margin (2016-2021)
16.2 Perrigo Company
16.2.1 Company Profile
16.2.2 Main Business and Motion Sickness Treatment Information
16.2.3 SWOT Analysis of Perrigo Company
16.2.4 Perrigo Company Motion Sickness Treatment Sales, Revenue, Price and Gross Margin (2016-2021)
16.3 Prestige Brands
16.3.1 Company Profile
16.3.2 Main Business and Motion Sickness Treatment Information
16.3.3 SWOT Analysis of Prestige Brands
16.3.4 Prestige Brands Motion Sickness Treatment Sales, Revenue, Price and Gross Margin (2016-2021)
16.4 WellSpring Pharmaceutical Corporation
16.4.1 Company Profile
16.4.2 Main Business and Motion Sickness Treatment Information
16.4.3 SWOT Analysis of WellSpring Pharmaceutical Corporation
16.4.4 WellSpring Pharmaceutical Corporation Motion Sickness Treatment Sales, Revenue, Price and Gross Margin (2016-2021)
16.5 Caleb Pharmaceuticals
16.5.1 Company Profile
16.5.2 Main Business and Motion Sickness Treatment Information
16.5.3 SWOT Analysis of Caleb Pharmaceuticals
16.5.4 Caleb Pharmaceuticals Motion Sickness Treatment Sales, Revenue, Price and Gross Margin (2016-2021)
16.6 Myungmoon Pharm
16.6.1 Company Profile
16.6.2 Main Business and Motion Sickness Treatment Information
16.6.3 SWOT Analysis of Myungmoon Pharm
16.6.4 Myungmoon Pharm Motion Sickness Treatment Sales, Revenue, Price and Gross Margin (2016-2021)
16.7 Baxter International
16.7.1 Company Profile
16.7.2 Main Business and Motion Sickness Treatment Information
16.7.3 SWOT Analysis of Baxter International
16.7.4 Baxter International Motion Sickness Treatment Sales, Revenue, Price and Gross Margin (2016-2021)
16.8 Reliefband Technologies
16.8.1 Company Profile
16.8.2 Main Business and Motion Sickness Treatment Information
16.8.3 SWOT Analysis of Reliefband Technologies
16.8.4 Reliefband Technologies Motion Sickness Treatment Sales, Revenue, Price and Gross Margin (2016-2021)
For more information about this report visit https://www.researchandmarkets.com/r/63yozz
